Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MD Farma is a Turkish specialty pharmaceutical company that focuses on the marketing, sales, and distribution of innovative healthcare solutions. Founded in 2007 and based in Istanbul, the company specializes in therapeutic areas such as dermatology, gynecology, urology, and pediatrics. MD Farma acts as a strategic partner for international pharmaceutical firms, licensing and launching specialized products like MolluDerm for molluscum contagiosum and Zindaclin for acne in the Turkish market. The company's operations are supported by a dedicated medical promotion team that engages with healthcare professionals to drive product adoption. Their portfolio encompasses a mix of prescription medicines, medical devices, and dermo-cosmetic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MD Farma.